Table 1 Demographical characteristics
LaTME | TaTME | p value | |
|---|---|---|---|
Number of patients | 23 | 23 | – |
Age (median, IQR) | 64 [58–67] | 60 [51–67] | 0.41 |
Sex (women) | 10 (31%) | 10 (31%) | 0.37 |
BMI (kg/m2; median, IQR) | 26.5 [23.8–30.6] | 26 [22.8–29.7] | 0.43 |
Distance of the tumor from the anal verge (cm; median, IQR) | 4 [3–5] | 3[2–4] | 0.01 |
ASA I/II/III | 2/16/5 | 3/15/6 | 0.60 |
Preoperative neoadjuvant treatment (yes/no) | 19/4 | 18/5 | 0.71 |
Adjuvant treatment (yes/no) | 15/8 | 13/10 | 0.54 |
Type of anastomosis (stapled/hand-sewn) | 21/2 | 21/2 | 1.00 |
Clinical TNM before neoadjuvant treatment | |||
cT1/2/3/4 | 3/6/12/2 | 2/3/15/3 | 0.24 |
cN | 13/23 | 14/23 | 0.76 |
Postoperative LARS incidence | |||
No LARS | 2 (9%) | 3 (13%) | 0.63 |
Minor LARS | 9 (39%) | 12 (52%) | 0.37 |
Major LARS | 12 (52%) | 8 (35%) | 0.23 |
Preoperative LARS Score (median, IQR) | 0 [0–5] | 5 [0–21] | 0.10 |
Postoperative LARS score (median, IQR) | 30 [21–34] | 29 [24–34] | 0.76 |
Preoperative Wexner (median, IQR) | 0 [0–1] | 0 [0–2] | 0.20 |
Postoperative Wexner (median, IQR) | 7 [3–11] | 8 [4–12] | 0.83 |